Community Health Navigator Program for Chronic Kidney Diseases
This study is evaluating whether a patient navigation program can improve care for patients with multiple long-term health conditions.
See full descriptionAbout the trial for Chronic Kidney Diseases
Treatment Groups
This trial involves 2 different treatments. Community Health Navigator Program is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Community Health Navigator Program will improve 1 primary outcome and 33 secondary outcomes in patients with Chronic Kidney Diseases. Measurement will happen over the course of Up to 12 months.
Patient Q & A Section
What are the signs of chronic kidney diseases?
The prevalence of CKDs among a cohort of CKD-prone African Canadians was greater than anticipated in that age group. CKD was more prevalent in women than in men, and older age was a negative predictor of CKD.
What causes chronic kidney diseases?
The cause(s) of CKDs seem to be multifactorial, involving different pathways which may be related and interacting with the genetic factor. The environmental factors such as diabetes, hypertension, hypertension-kidney diseases, and other factors also appear to be involved.
How many people get chronic kidney diseases a year in the United States?
A significant proportion of patients with CKD die of unknown etiology. The data collected here are applicable to the whole United States population, therefore they can be used to estimate the burden of disease related to CKD in the US.
What is chronic kidney diseases?
CKD is a frequent and disabling kidney disease. A high proportion of patients has chronic kidney disease when they are diagnosed with CKD, and CKD is a major cause of advanced end stage kidney disease.
Can chronic kidney diseases be cured?
Although it often seems as if the medical profession has come close to achieving the 'cure' of advanced chronic kidney diseases, its effectiveness is currently limited to the initial alleviation of their clinical manifestations.
What are common treatments for chronic kidney diseases?
The majority of treatments for CKD have high efficacy, mostly due to effective and tolerable dosing regimens, but the most prescribed medications may cause severe adverse events or lead to a less effective dosing regimen.
What is the primary cause of chronic kidney diseases?
Results from a recent paper suggest that the main causative factor for prevalent CKD, regardless of the underlying causes of CKD, is long-term exposure to environmental toxins. For the primary prevention of CKD we suggest the substitution of traditional tobacco smoking with the use of herbal products or herbal cigarette.
How serious can chronic kidney diseases be?
The CKD-EPI equation overestimates eGFR for patients with severe chronic kidney diseases. However, the CKD-EPI equation has good clinical applicability and is probably not applicable for all patient groups. We conclude that it can be used to define stages of CKD and may be used for the clinical risk prediction in patients with CKD and also as a reference in clinical practice.
Is community health navigator program safe for people?
Community health navigation is as safe as usual care in selected patient populations, especially for low-risk patients with chronic kidney disease. Although no adverse events were noted, it appeared that navigation increased communication between primary care providers and patients.
Have there been other clinical trials involving community health navigator program?
The CHNP model effectively reduces disparities in diabetes care and reduces patient-centered diabetes care. The study did not support the CHNP model as a stand-alone intervention that increases participation in diabetes care and outcomes in the home setting.
Is community health navigator program typically used in combination with any other treatments?
Although navigation and CPN programs are widely used in many countries, they were used in combination with any other treatment in only 10% of studies. This raises the possibility that they may work synergistically. There has been speculation that CPN may have the potential to improve the quality of care by increasing awareness of patients' social and environmental needs that are otherwise missed by health professionals. To evaluate the effectiveness of CPN, well-designed randomized controlled trials are needed to determine whether such programs have any clinical effect on patient outcome (e.g., prolonging survival or improving patient-reported HRQOL).
What are the common side effects of community health navigator program?
The PHNN program in this study was proven successful in facilitating communication between the PHNN program and its participants regarding the course of the program and their treatment. Participants reported a high satisfaction rate with PHNN. With improvements in technology, patient-health navigator communication is easier than before.